Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) -- The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an...

New data shows more needs to be done to keep kids with diabetes safe at school OTTAWA, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Nearly one-third of Ontario parents aren’t confident that school staff can keep their kids with type 1 diabetes safe, according to new data released today...

Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment NEW YORK, NY--(Marketwired - February 08, 2016) - Johnson & Johnson (J&J), like much of the biopharmaceutical industry worldwide, is aware of the desperate necessity for a Type 1...

Helmsley Charitable Trust Awards $3.9 Million to 29 Type 1 Diabetes Camp Organizations NEW YORK, April 24, 2013 (GLOBE NEWSWIRE) -- The Helmsley Charitable Trust today announces that it has approved new grants totaling more than $3.9 million to 29 camp organizations to fund nearly 7,800...